|
|
|
|
| LEADER |
00000cam a2200000Mu 4500 |
| 001 |
EBSCO_on1108526327 |
| 003 |
OCoLC |
| 005 |
20231017213018.0 |
| 006 |
m o d |
| 007 |
cr |n|---||||| |
| 008 |
190713s2018 gw o 000 0 eng d |
| 040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d OCLCQ
|d N$T
|d OCLCF
|d OCLCO
|d OCLCQ
|d OCLCO
|
| 019 |
|
|
|a 1264802637
|
| 020 |
|
|
|a 3736987684
|
| 020 |
|
|
|a 9783736987685
|q (electronic bk.)
|
| 029 |
1 |
|
|a AU@
|b 000073108532
|
| 035 |
|
|
|a (OCoLC)1108526327
|z (OCoLC)1264802637
|
| 050 |
|
4 |
|a RM162
|
| 082 |
0 |
4 |
|a 615.6
|2 23
|
| 049 |
|
|
|a UAMI
|
| 100 |
1 |
|
|a Fei, Yang.
|
| 245 |
1 |
0 |
|a Mechanistic Understanding of Enhanced Human Oral Bioavailability of Fenofibric Acid from Novel Lipid Carriers Using Semi- Physiologically Based Pharmacokinetic Model and Various Analytical Approaches Including Biorelevant Dissolution Testing
|
| 260 |
|
|
|a Göttingen :
|b Cuvillier Verlag,
|c 2018.
|
| 300 |
|
|
|a 1 online resource (223 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 588 |
0 |
|
|a Print version record.
|
| 590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
| 650 |
|
0 |
|a Fenofibrate.
|
| 650 |
|
0 |
|a Lipids.
|
| 650 |
|
0 |
|a Drug delivery systems.
|
| 650 |
|
0 |
|a Oral medication.
|
| 650 |
|
2 |
|a Fenofibrate
|
| 650 |
|
2 |
|a Lipids
|
| 650 |
|
2 |
|a Drug Delivery Systems
|
| 650 |
|
2 |
|a Administration, Oral
|
| 650 |
|
6 |
|a Fénofibrate.
|
| 650 |
|
6 |
|a Lipides.
|
| 650 |
|
6 |
|a Systèmes d'administration de médicaments.
|
| 650 |
|
6 |
|a Médicaments
|x Administration par voie orale.
|
| 650 |
|
7 |
|a lipid.
|2 aat
|
| 650 |
|
7 |
|a Drug delivery systems
|2 fast
|
| 650 |
|
7 |
|a Fenofibrate
|2 fast
|
| 650 |
|
7 |
|a Lipids
|2 fast
|
| 650 |
|
7 |
|a Oral medication
|2 fast
|
| 776 |
0 |
8 |
|i Print version:
|a Fei, Yang.
|t Mechanistic Understanding of Enhanced Human Oral Bioavailability of Fenofibric Acid from Novel Lipid Carriers Using Semi- Physiologically Based Pharmacokinetic Model and Various Analytical Approaches Including Biorelevant Dissolution Testing.
|d Göttingen : Cuvillier Verlag, ©2018
|z 9783736997684
|
| 856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2130446
|z Texto completo
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL5407560
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 2130446
|
| 994 |
|
|
|a 92
|b IZTAP
|
